BackgroundTrachoma is the leading infectious cause of blindness due to conjunctival
infection with Chlamydia trachomatis. The presence of
active trachoma and evidence of infection are poorly correlated and a strong
immunologically-mediated inflammatory response means that clinical signs
last much longer than infection. This population-based study in five
Aboriginal communities endemic for trachoma in northern Australia compared a
fine grading of clinical trachoma with diagnostic positivity and organism
load.MethodsA consensus fine grading of trachoma, based on clinical assessment and
photograding, was compared to PCR, a lipopolysacharide (LPS)-based
point-of-care (POC) and a 16S RNA-based nucleic acid amplification test
(NAAT). Organism load was measured in PCR positive samples.ResultsA total of 1282 residents, or 85.2% of the study population, was
examined. Taking the findings of both eyes, the prevalence of trachomatous
inflammation-follicular (TF) in children aged 1–9 years was
25.1% (96/383) of whom 13 (13.7%) were PCR positive on the
left eye. When clinical data were limited to the left eye as this was tested
for PCR, the prevalence of TF decreased to 21.4% (82/383). The 301 TF
negative children, 13 (4.3%) were PCR positive. The fine grading of
active trachoma strongly correlated with organism load and disease severity
(rs = 0.498,
P = 0.0004). Overall, 53% of
clinical activity (TF1 or TF2) and 59% of PCR
positivity was found in those with disease scores less than the WHO
simplified grade of TF.ConclusionDetailed studies of the pathogenesis, distribution and natural history of
trachoma should use finer grading schemes for the more precise
identification of clinical status. In low prevalence areas, the LPS-based
POC test lacks the sensitivity to detect active ocular infection and nucleic
acid amplification tests such as PCR or the 16S-RNA based NAAT performed
better. Trachoma in the Aboriginal communities requires specific control
measures.